Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.23 CNY
1.25 B CNY
5.48 B CNY
226.64 M
About BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD.
Sector
Industry
CEO
Zhiming Jiang
Website
Headquarters
Beijing
Founded
1991
ISIN
CNE100004090
FIGI
BBG00D70GDJ7
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 603392 is 73.81 CNY — it has decreased by −1.76% in the past 24 hours. Watch BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stocks are traded under the ticker 603392.
603392 stock has risen by 3.14% compared to the previous week, the month change is a −9.42% fall, over the last year BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. has showed a 49.35% increase.
We've gathered analysts' opinions on BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. future price: according to them, 603392 price has a max estimate of 74.30 CNY and a min estimate of 48.50 CNY. Watch 603392 chart and read a more detailed BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock forecast: see what analysts think of BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. and suggest that you do with its stocks.
603392 reached its all-time high on Apr 21, 2022 with the price of 131.99 CNY, and its all-time low was 3.69 CNY and was reached on Apr 29, 2020. View more price dynamics on 603392 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
603392 stock is 3.11% volatile and has beta coefficient of 1.18. Track BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock price on the chart and check out the list of the most volatile stocks — is BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. there?
Today BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. has the market capitalization of 94.99 B, it has decreased by −5.92% over the last week.
Yes, you can track BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. financials in yearly and quarterly reports right on TradingView.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
603392 earnings for the last quarter are 0.11 CNY per share, whereas the estimation was 0.11 CNY resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.13 CNY per share. See more details about BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. earnings.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. revenue for the last quarter amounts to 695.82 M CNY, despite the estimated figure of 695.82 M CNY. In the next quarter, revenue is expected to reach 721.41 M CNY.
603392 net income for the last quarter is 6.17 M CNY, while the quarter before that showed 134.77 M CNY of net income which accounts for −95.42% change. Track more BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. financial stats to get the full picture.
Yes, 603392 dividends are paid annually. The last dividend per share was 0.32 CNY. As of today, Dividend Yield (TTM)% is 0.43%. Tracking BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. dividends might help you take more informed decisions.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. dividend yield was 0.43% in 2023, and payout ratio reached 32.32%. The year before the numbers were 0.56% and 13.45% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 8, 2024, the company has 3.84 K employees. See our rating of the largest employees — is BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. on this list?
Like other stocks, 603392 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. stock shows the buy signal. See more of BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO.，LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.